Publication | Closed Access

848a Lubiprostone Significantly Improves Treatment Response in Non-Methadone Opioid-Induced Bowel Dysfunction Patients with Chronic, Non-Cancer Pain: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Pain TherapyPain MedicineGastroenterologyPharmacotherapyOncologyAddiction MedicinePain ManagementAnalgesicsHealth SciencesTreatment ResponseOpioid Use DisorderPharmacologyPain ResearchAddictionCancer PainOpioid OverdoseLubiprostone SignificantlyMedicinePhase 3